title: Protective effect of E3330, a novel quinone derivative, in galactosamine-induced hepatitis in rats.
abstract: The effect of E3330 ((2E)-3-[5-(2,3-dimethoxy-6-methyl-1,4-benzoquinoyl)]-2-nonyl-2-++ +propenoic acid), a novel quinone derivative, was studied in the galactosamine-induced hepatitis model in F344 rats, in which endogenous endotoxin is believed to play a critical pathogenetic role. Subcutaneous injection of 300 mg/kg of galactosamine into rats resulted in liver injury. Oral treatment with E3330 (10-100 mg/kg) 1 hr after galactosamine challenge attenuated the liver injury. E3330 was also effective when administered p.o. 6 or 12 hr after galactosamine challenge. Subcutaneous injection of 1000 mg/kg of galactosamine into rats resulted in more severe liver injury with endotoxemia. The plasma endotoxin was detected 24 to 48 hr after the galactosamine challenge. The time course of increase in plasma endotoxin level was in good agreement with that in plasma aminotransferase activity. E3330 (100 mg/kg) significantly attenuated the liver injury, but did not affect the endotoxin level. Exogenous administration of endotoxin enhanced the hepatotoxicity of galactosamine. Pretreatment with E3330 also protected rats from severe liver injury induced with endotoxin plus galactosamine. These results suggest that E3330 may exert its hepatoprotective effects through inhibition of an effect of endotoxin in galactosamine-induced hepatitis in rats.
authors.affiliation: Tsukuba Research Laboratories, Eisai Co., Ltd., Ibaraki, Japan.
authors.forename: J
authors.initials: J
authors.lastname: Nagakawa
authors.forename: K
authors.initials: K
authors.lastname: Hirota
authors.forename: I
authors.initials: I
authors.lastname: Hishinuma
authors.forename: K
authors.initials: K
authors.lastname: Miyamoto
authors.forename: J
authors.initials: J
authors.lastname: Sonoda
authors.forename: T
authors.initials: T
authors.lastname: Yamanaka
authors.forename: K
authors.initials: K
authors.lastname: Katayama
authors.forename: I
authors.initials: I
authors.lastname: Yamatsu
mesh_terms: D000818:Animals; D016227:Benzoquinones / Q000627:therapeutic use*; D056486:Chemical and Drug Induced Liver Injury / Q000188:drug therapy / Q000517:prevention & control*; D004195:Disease Models, Animal; D004731:Endotoxins / Q000097:blood / Q000502:physiology; D005688:Galactosamine; D008070:Lipopolysaccharides; D008297:Male; D011422:Propionates / Q000627:therapeutic use*; D051381:Rats; D011916:Rats, Inbred F344
chemical_list: D016227:Benzoquinones; D004731:Endotoxins; D008070:Lipopolysaccharides; D011422:Propionates; C075569:E 3330; D005688:Galactosamine